Taiwan News12h
Rapid-Acting Insulin Market Growth Outlook, Revenue Forecast, and Trends (2020-2027)
However, the reluctance in adoption of rapid acting insulin due to the side effect, such as hypoglycemia, may hinder the growth of the industry. Conversely, untapped market and undiagnosed population ...
Study suggests inhaled technosphere insulin could be considered as an option for adults with type 1 diabetes
A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) ...
EurekAlert!6d
Evaluation of inhaled technosphere insulin plus insulin degludec for adults with type 1 diabetes
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...
Richmond Times-Dispatch7d
Petersburg drugmaker Civica misses target for selling cheap insulin
The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.
Becker's Hospital Review13d
Inside Civica Rx’s 2025 sourcing, expansion strategies
"Discover Civica Rx's plans for 2025, including launching new medications from their plant, expanding insulin program, and ...
Medical News Today14d
4 natural ways to improve insulin sensitivity
High insulin sensitivity allows the body’s cells to use blood glucose more effectively, reducing blood sugar. Some lifestyle, self-care, and dietary changes may help increase insulin sensitivity.
Daily18d
Biocon Biologics, Civica join hands to expand Insulin Aspart access in US
Under the terms of the agreement, Biocon Biologics will supply Insulin Aspart drug substance to Civica, Inc., who will use the drug substance to produce Insulin Aspart drug product, a rapid-acting ...
Indiatimes18d
Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US
Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will supply the insulin, while Civica will manufacture and commercialize it, ...
Business Standard18d
Stock Alert: TCS, Power Grid Corporation, NMDC, Biocon, Firstsource Solutions
Biocons subsidiary, Biocon Biologics, announced a strategic collaboration agreement with Civica, Inc. to expand access and affordability of Insulin Aspart in the United States. As per the agreement, ...
Pharmabiz18d
Biocon Biologics and Civica collaborate to expand insulin aspart access in the US
Under the terms of the agreement, Biocon Biologics will supply insulin aspart drug substance to Civica, who will use the drug substance to produce insulin aspart drug product, a rapid-acting insulin ...
moneycontrol.com19d
Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March
The company's subsidiary, Biocon Biologics, announced a strategic collaboration agreement with Civica, Inc. to expand access and affordability of Insulin Aspart in the United States. As per the ...
tradebrains19d
Pharma stock jumps after partnering with Civica to expand Insulin Aspart access in US
The shares of the biopharmaceutical company jumped up to 2 percent after the company announced a collaboration to expand Insulin Aspart access in the United States. The shares of Biocon Ltd have seen ...